CNS Pharmaceuticals CNSP Q3 2024 earnings
Reported November 14, 2024 · Before market open
EPS estimate-$0.10
Next report
Aug 17, 2026 (in a month)EPS estimate-$0.24
Versus estimates
Diluted EPS
Ask the moment CNS Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did CNS Pharmaceuticals report Q3 2024 earnings?
- CNS Pharmaceuticals (CNSP) reported Q3 2024 earnings on November 14, 2024 before market open.
- What were CNS Pharmaceuticals's Q3 2024 revenue and EPS?
- CNS Pharmaceuticals reported diluted EPS of $-150.06 for Q3 2024.
- Did CNS Pharmaceuticals beat estimates in Q3 2024?
- EPS missed the consensus estimate of $-0.10 by $149.96.
- Where can I find CNS Pharmaceuticals's Q3 2024 SEC filings?
- You can read the 10-Q periodic report (0001683168-24-008125) directly on SEC EDGAR. The filing index links above go to sec.gov.